Completed NA INTERVENTIONAL NCT00001991
A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia
Sponsor: Glaxo Wellcome
Conditions
HIV Infections Pneumonia, Pneumocystis Carinii
Interventions
Atovaquone
Updated 5 times since 2017 Last updated: Jun 23, 2005
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT00001991, this NA trial focuses on HIV Infections and Pneumonia, Pneumocystis Carinii and remains completed. Sponsored by Glaxo Wellcome, it has been updated 5 times since 2026, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Glaxo Wellcome
Data source: NIH AIDS Clinical Trials Information Service
For direct contact, visit the study record on ClinicalTrials.gov .